3-D Matrix, Ltd.
OTC: DMTRF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Keiji Nagano
- Employees
- 106
- Headquarters
- Tokyo, Japan
- IPO year
- 2013
- Market cap
- $270.5M
- Website
- https://www.3d-matrix.co.jp
Loading DMTRF…
Loading profile data…Frequently asked questions about DMTRF
What does 3-D Matrix, Ltd. (DMTRF) do?
3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications. This Tok...
Where does DMTRF trade?
3-D Matrix, Ltd. (DMTRF) trades on the Other OTC.
What sector is DMTRF in?
3-D Matrix, Ltd. (DMTRF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of 3-D Matrix, Ltd.?
Keiji Nagano is the chief executive officer of 3-D Matrix, Ltd. (DMTRF).
Where is 3-D Matrix, Ltd. headquartered?
3-D Matrix, Ltd. is headquartered in Japan.
Does DMTRF pay a dividend?
3-D Matrix, Ltd. (DMTRF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did DMTRF go public?
3-D Matrix, Ltd. (DMTRF) completed its initial public offering in 2013.